Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR submitted a Form 144 disclosing proposed sales of Common stock and recent restricted‑stock vesting events. The filing lists restricted stock vesting of 558 shares on 01/27/2025 and 1,158 shares on 04/11/2025. It also reports a sale of 4,546 shares on 01/22/2026 for $142,750.68. The filing references NASDAQ and includes a filing date of 04/16/2026.
AEHR Technologies: Rule 144 notice reporting recent share dispositions. The filing lists an intended sale of 8,000 shares and reports two past dispositions: 3,500 shares sold on 04/10/2026 for $245,157.90 and 7,000 shares sold on 04/13/2026 for $500,430.70. The record references an option granted on 05/10/2021 and a cash settlement method.
AEHR reported proposed sales of common stock tied to restricted stock vesting and broker holdings as shown on the notice. The filing lists multiple vesting events (e.g., 319, 499, 1,417 shares) with specific vesting dates in 01/2024–04/2024
AEHR notice of proposed sales of common stock by an affiliate and scheduled restricted stock vestings. The filing lists two recent dispositions by Alistair N. Sporck: 3,000 shares on 02/09/2026 for $82,715.25 and 2,000 shares on 04/10/2026 for $134,730.00. The filing also lists multiple restricted stock vesting events from 04/18/2024 through 07/18/2025 with individual grant counts of 57, 329, 533, 150, 265, 267, and 399 shares tied to compensation.
Aehr Test Systems director Geoffrey Scott Gates filed an amended Form 4 to correct details of previously reported stock sales on April 9, 2026. The amendment updates share counts and prices for his spouse’s indirect open-market sales of company common stock.
The corrected data show three sales totaling 40,000 shares of common stock at prices of $68.00, $68.12, and $67.79 per share. After these transactions, his spouse held 100,000 shares indirectly, while he also held 52,864 shares directly and 60,686 shares indirectly through a trust.
AEHR Test Systems executive Didier Wimmers reported open-market sales of 5,400 shares of common stock. He sold 3,500 shares on April 13, 2026 at an average price of $71.1102 per share and 1,900 shares on April 15, 2026 at an average price of $72.0239.
After these transactions, Wimmers directly holds 10,659 shares of AEHR common stock, and this amount includes shares subject to unvested restricted stock units. All reported transactions were classified as open-market sales.
Aehr Test Systems CTO Donald P. Richmond II sold 17,011 shares of Common Stock in an open-market transaction. The shares were sold at an average price of $73.1764 per share. Following this sale, he directly holds 181,512 shares, which include shares subject to unvested restricted stock units.
AEHR Technologies submitted a Form 144 sale notice for Common Stock tied to restricted stock vesting. The filing lists four vesting entries of 295, 575, 511 and 519 shares with vesting dates shown as 06/03/2025, 09/03/2025, 12/03/2025 and 03/03/2026. The broker listed is Fidelity Brokerage Services LLC.
AEHR Test Systems President and CEO Gayn Erickson had 2,784 shares of common stock withheld at $74.38 per share to cover tax obligations when restricted stock units and restricted shares vested. This was a tax-withholding event, not an open-market sale. After these withholdings, he holds 185,511 shares directly and 197,723 shares indirectly through a trust, including unvested restricted stock units and restricted shares.
AEHR Test Systems CFO Chris Siu reported a routine tax-related share withholding tied to equity compensation. On the RSU vesting date, 697 shares of common stock were withheld at an implied price of $70.43 per share to satisfy tax withholding obligations, and this was not an open-market sale. Following the withholding, Siu directly owns 70,740 common shares. He also has 7,306 shares held indirectly through a trust, and this amount includes shares subject to unvested restricted stock units.